Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Northwest Biotherapeutics Inc
NWBOCurrent price
0.29 USD
-0.0043 USD (-1.46%)
Last closed
0.3 USD
Company
www.nwbio.com
ISIN
US66737P6007
Sector
Healthcare
Industry
Biotechnology
Exchange
OTCQB
Capitalization
374 472 000 USD
Yield for 12 month
-65.57 %
1Y
3Y
5Y
10Y
15Y
NWBO
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland. Address: 4800 Montgomery Lane, Bethesda, MD, United States, 20814
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5 USDP/E ratio
–Dividend Yield
–Current Year
+1 932 000 USD
Last Year
+1 683 000 USD
Current Quarter
+510 000 USD
Last Quarter
+284 000 USD
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures NWBO
1 year
3 years
5 years
10 years
EBITDA
-60 473 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-137.16 %
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
5 USD
Revenue TTM
1 645 000 USD
Book Value
-0.062 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
153.7 %
Dividend Yield
–
Gross Profit TTM
-33 828 000 USD
Earnings per share
-0.07 USD
Diluted Eps TTM
-0.07 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics NWBO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NWBO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:16
Payout Ratio
–
Last Split Date
26.09.2012
Dividend Date
–
Stock Valuation NWBO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
263.3924
Price Sales TTM
227.6426
Enterprise Value EBITDA
-11.9051
Price Book MRQ
–
Financials NWBO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NWBO
For 52 weeks
0.24 USD
0.91 USD
50 Day MA
0.3 USD
Shares Short Prior Month
13 831 447
200 Day MA
0.43 USD
Short Ratio
13.54
Shares Short
14 142 788
Short Percent
15.09 %
BeatStart